Show simple item record

FieldValueLanguage
dc.contributor.authorSchloss, Janeten_AU
dc.contributor.authorLauche, Romyen_AU
dc.contributor.authorHarnett, Joanneen_AU
dc.contributor.authorHannan, Nicoleen_AU
dc.contributor.authorBrown, Danielleen_AU
dc.contributor.authorGreenfield, Tomen_AU
dc.contributor.authorSteel, Amieen_AU
dc.date.accessioned2020-08-14
dc.date.available2020-08-14
dc.date.issued2020en_AU
dc.identifier.urihttps://hdl.handle.net/2123/23080
dc.description.abstractCurrent evidence from published systematic reviews indicate that oral intake of vitamin C may assist with symptoms of acute viral respiratory infections (ARI) by reducing fever and chills, relieving chest pain and assist in reducing symptoms of common cold-induced asthma. Intravenous (IV) vitamin C administration may reduce the need for vasopressor support and the duration of mechanical ventilations in critically ill patients in hospital. COVID-19 has similar signs and symptoms of ARI. Further studies involving patients with COVID-19, either through administration of oral vitamin C in mild cases or IV vitamin C in critical cases, would be advantageous to examine if it is safe and efficacious.en_AU
dc.language.isoenen_AU
dc.subjectCOVID-19en_AU
dc.subjectCoronavirusen_AU
dc.titleRapid review of Systematic reviews on the efficacy and safety of Vitamin C in the management of Acute Respiratory Infection and Disease Authorsen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1016/j.aimed.2020.07.008


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.